Fresenius SE Market Cap 2016-2023 | FSNUY

Fresenius SE market cap history and chart from 2016 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Fresenius SE market cap as of April 26, 2024 is $16.46B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.465B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $15.044B 15.55
DaVita (DVA) United States $11.644B 15.84
Chemed (CHE) United States $8.667B 26.91
Encompass Health (EHC) United States $8.285B 21.32
Elanco Animal Health (ELAN) United States $6.443B 14.65
Option Care Health (OPCH) United States $5.091B 19.27
RadNet (RDNT) United States $3.345B 97.70
Amedisys (AMED) United States $2.978B 21.10
LifeStance Health (LFST) United States $2.355B 0.00
Astrana Health (ASTH) United States $2.048B 25.57
U.S Physical Therapy (USPH) United States $1.513B 39.21
Addus HomeCare (ADUS) United States $1.501B 22.81
Pennant (PNTG) United States $0.610B 35.63
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.308B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.006B 0.00